Document is current
Any future updates will be listed below
-
Authors
Pareto, Deborah https://orcid.org/0000-0001-7356-3769
Naval-Baudin, Pablo
Pons-Escoda, Albert
Bargalló, Núria
Garcia-Gil, María
Majós, Carlos
Rovira, Àlex
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/01709)
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 20 April 2025
First Online: 28 May 2025
Declarations
:
: This manuscript is a review article and, as such, did not involve original research or any direct interaction with human or animal subjects. Consequently, formal ethical approval was not required for the preparation of this manuscript. Similarly, informed consent does not apply as this work is solely based on published literature and involves no primary data collection from participants.
: This manuscript is a review article and, as such, did not involve original research or any direct interaction with human or animal subjects. Consequently, formal ethical approval was not required for the preparation of this manuscript. Similarly, informed consent does not apply as this work is solely based on published literature and involves no primary data collection from participants.
: D Pareto has nothing to disclose.P Naval-Baudin has nothing to disclose.A Pons-Escoda has nothing to disclose.N Bargalló has nothing to disclose.M Garcia-Gil has nothing to disclose.C Majós has nothing to disclose.À Rovira serves/ed on scientific advisory boards for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, and Biogen, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers and Biogen, is CMO and co-founder of TensorMedical, and receives research support from Fondo de Investigación en Salud (PI19/00950 and PI22/01589) from Instituto de Salud Carlos III, Spain.
